These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 4223122

  • 1. Studies on progressive muscular dystrophy. I. Effects of adenosinetriphosphate and its related compounds on progressive muscular dystrophy.
    Nakahara M.
    Arzneimittelforschung; 1965 Jun; 15(6):591-5. PubMed ID: 4223122
    [No Abstract] [Full Text] [Related]

  • 2. [Therapeutic possibilities in progressive muscular dystrophy].
    Beckmann R, von Osten V.
    Dtsch Med Wochenschr; 1966 Jan 21; 91(3):108-16. PubMed ID: 5901816
    [No Abstract] [Full Text] [Related]

  • 3. Studies on progressive muscular dystrophy. II. Relation between clinical effect of adenosinetriphosphate on progressive muscular dystrophy and phosphate compounds in the muscle.
    Nakahara M.
    Arzneimittelforschung; 1965 Jul 21; 15(7):782-5. PubMed ID: 5898681
    [No Abstract] [Full Text] [Related]

  • 4. [Effects of administration of phosphocreatine on the clinical, biochemical and electromyographic evolution of Duchenne's progressive muscular dystrophy].
    Radu H, Keresztes L, Stenzel K.
    Minerva Med; 1968 Dec 12; 59(99):5524-9. PubMed ID: 5718841
    [No Abstract] [Full Text] [Related]

  • 5. [Effect of drug administration on the child with progressive muscular dystrophy].
    Nakahara T, Annaka S, Baba T, Kanno M.
    Iryo; 1969 Oct 12; 23(10):1319-27. PubMed ID: 5364983
    [No Abstract] [Full Text] [Related]

  • 6. [New aspects of the management of progressive muscular dystrophy].
    Tilscher H, Schenk S.
    Wien Med Wochenschr; 1967 Nov 04; 117(44):1000-2. PubMed ID: 5591872
    [No Abstract] [Full Text] [Related]

  • 7. [The treatment of progressive muscular dystrophy with nucleosides and nucleotides. Clinical and serologic findings (aldolase and creatinphosphokinase)].
    Ceccarelli A, Leone P, Moretti A.
    Clin Pediatr (Bologna); 1967 Sep 04; 49(9):468-75. PubMed ID: 5608288
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Studies on progressive muscular dystrophy. IV. Effects of original amino acids mixture on progressive muscular dystrophy.
    Nakahara M, Yamada S.
    Arzneimittelforschung; 1967 Jun 04; 17(6):753-6. PubMed ID: 5632380
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [On the effect of corticoid administration on creatine phosphokinase in progressive muscular dystrophy].
    Barthelmai W.
    Verh Dtsch Ges Inn Med; 1965 Jun 04; 71():624-6. PubMed ID: 5877674
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. ATP- and ADP-induced rat platelet aggregation: significance of plasma in ATP-induced aggregation.
    Haskel EJ, Agarwal KC, Parks RE.
    Thromb Haemost; 1980 Feb 29; 42(5):1580-8. PubMed ID: 7368159
    [No Abstract] [Full Text] [Related]

  • 20. [Progressive muscular dystrophy. Results of a therapeutic trial with glucose-insulin infusions].
    Zett W, Goehler I.
    Kinderarztl Prax; 1969 Jul 29; 37(7):312-24. PubMed ID: 5355989
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.